European Medicine Agency (EMA) Endorses New Medicine For Cystic Fibrosis Patients
European Medicine Agency (EMA) has recommended granting a marketing authorisation in the European Union for Kaftrio, the first triple combination therapy for the treatment of cystic fibrosis in patients aged…
Share